The Global Trade Research Institute (GTRI) has called on India to reassess its trade agreement with the United States after the US Supreme Court ruled that President Donald Trump exceeded
Your blog category
The Global Trade Research Institute (GTRI) has called on India to reassess its trade agreement with the United States after the US Supreme Court ruled that President Donald Trump exceeded
Bangladesh cricket team’s senior assistant coach Mohammad Salahuddin condemned recent statements by Muhammad Yunus’ sports advisor Asif Nazrul, challenging both the reasoning and the impact of the move. The boycott,
New Delhi, Feb 20: Production growth of India’s eight key infrastructure sectors slowed down to a two-month low of 4 per cent in January, according to official data released on
US President Donald Trump on Friday attacked the US Supreme Court after it struck down the reciprocal tariffs imposed by his administration on Liberation Day last year. Trump said that
US President Donald Trump on Saturday said that there would be no change in the India-US trade deal despite the Supreme Court striking down his earlier reciprocal tariffs. Trump told
Amid the accelerating shift toward artificial intelligence in the workplace, Accenture has told senior employees that consistent use of its AI tools will play a direct role in determining promotions
India has given assurances regarding its purchases of Russian crude, US Ambassador Sergio Gor said on February 20, indicating that Washington and New Delhi have reached an understanding as they
OTT Release this Week: इस हफ्ते ओटीटी प्लेटफॉर्म्स पर एंटरटेनमेंट का जबरदस्त डोज मिलने वाला है, जहां क्राइम थ्रिलर से लेकर रोमांटिक कॉमेडी तक हर तरह का कंटेंट रिलीज हुआ
The February 4–6 meeting of the RBI’s Monetary Policy Committee (MPC) highlighted growing anxiety among global investors as financial markets continue to witness heightened volatility. Persistent geopolitical tensions and abrupt
Swiss drugmaker Novartis AG has signed an agreement with private equity firm ChrysCapital to transfer its 70.68% shareholding in Novartis India Limited (NIL), marking its exit from the listed Indian





